Practical Therapeutics: An Innovative Residency Drug Education Curriculum

Family Medicine

Volumn 36, Issue 4, 2004, Pages 236-238

  Cheng, Cynthia ^a   Umland, Elena ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF THE SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTINUING EDUCATION; CURRICULUM; DRUG EDUCATION CURRICULUM; DRUG INDUCED DISEASE; EDUCATION PROGRAM; EVIDENCE BASED MEDICINE; FAMILY MEDICINE; FEEDBACK SYSTEM; HEALTH CARE QUALITY; HUMAN; MEDICAL EDUCATION; PATIENT CARE; PHARMACOLOGY; PHARMACOTHERAPY EDUCATION; PRESCRIPTION; RESIDENCY EDUCATION; SATISFACTION; SCORING SYSTEM; STATISTICAL ANALYSIS;

AMBULATORY CARE; CLINICAL COMPETENCE; CURRICULUM; FAMILY PRACTICE; HUMANS; INTERNSHIP AND RESIDENCY; PHARMACOLOGY, CLINICAL; PROGRAM DEVELOPMENT; PROGRAM EVALUATION;

EID: 1942454754     PISSN: 07423225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system: quality of health care in America. Institute of Medicine. Washington, DC: National Academy Press, 2000.
2. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
3. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients: excess length of stay, extra costs, and attibutable mortality. JAMA 1997;277:301-6.
4. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA 1995;274:29-34.
5. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. JAMA 1997;277:307-11.
6. Monane M, Dipika DM, Nagle BA, et al. Improving prescribing patterns for the elderly through an on-line drug utilization review intervention. JAMA 1998;280:1249-52.
7. Lesar TS, Briceland L, Stein DS. Factors related to errors in medication prescribing. JAMA 1997;277:312-7.
8. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA 1995;274:35-43.
9. Brater DC, Nierenberg DW. Medical student education in clinical pharmacology and therapeutics. Ann Intern Med 1988;108:136-7.
10. Adcock BB, Byrd DC, O'Neal MR. The need for comprehensive pharmacotherapy curricula. Acad Med 1998;73:1126-7.
11. Rosebraugh CJ, Honig PK, Yasuda SU, Pezzullo JC, Woosley RL. Centers for Education and Research on Therapeutics report: survey of medication errors education during undergraduate and graduate medical education in the United States. Clin Pharmacol Ther 2002;71:4-10.
12. Sumpton JE, Frewen TC, Rieder MJ. The effect of physician education on knowledge of drug therapeutics and costs. Ann Pharmacother 1992;26:692-7.
13. Bates DW, Soldin SJ, Rainey PM, Micelli JN. Strategies for physician education in therapeutic drug monitoring. Clin Chem 1998;44:401-7.
14. Bucci KK, Frey KA. A description of a pharmacotherapy curriculum in a university-based family medicine program. Ann Pharmacother 1992;26:991-4.
15. Gray J, Lewis L, Nierenberg D. Clinical pharmacology education in primary care residency programs. Clin Pharmacol Ther 1997;62:237-40.
16. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) Study. Arch Intern Med 1999;159:1939-45.
17. Lee AJ, Boro MS, Knapp KK, Meier JL, Korman NE. Clinical and economic outcomes of pharmacist recommendations in a Veterans Affairs medical center. Am J Health Syst Pharm 2002;59:2070-7.
18. Ables AZ, Baughman OL. The clinical pharmacist as a preceptor in a family practice residency training program. Fam Med 2002;34(9):658-62.
19. Shaughnessy AF, Hume AL. Clinical pharmacists in family practice residency programs. J Fam Pract 1990;31:305-9.